The ‘memories’ of lung cancer cells can guide treatment improvement by unveiling their past responses to therapies. Scientists analyze these cellular memories using advanced sequencing techniques and assess how cancer cells adapt and evolve. Understanding these adaptive mechanisms helps in designing personalized treatments targeting specific vulnerabilities and resistant pathways, fostering more effective and tailored therapies against lung cancer.
Related Posts
AI-powered brain surgery: A new tool that could revolutionize how we treat brain cancer.
Scientists have developed an AI tool that can rapidly decode a brain tumour’s DNA to determine its molecular identity during surgery. This information can help surgeons decide how much brain tissue to remove and whether to place tumor-killing drugs directly into the brain.
Revolutionizing cancer care: Blood tests offer precise detection and monitoring.
Researchers enhance cancer detection and monitoring through blood tests by refining liquid biopsy techniques. Improved sensitivity allows the identification of minute amounts of circulating tumor DNA, RNA, or proteins, providing insights into cancer presence and characteristics. Advanced technologies, like next-generation sequencing, enable detailed genomic profiling for personalized treatment strategies. Regular blood tests facilitate real-time monitoring […]
Unleashing the Power of Human Genome Databases to Fight Cancer
Researchers at the University of Michigan have expanded the use of a gene sequencing method called ribosome profiling to understand protein production in cells. This method, also known as Ribo-seq, has the potential to advance cancer research by identifying new targets for immunotherapy and other treatment approaches. Ribo-seq works by taking a high-resolution snapshot of […]